REQUEST A DEMO
Total
USD $0.00
Search more companies

Abl Pharma Ecuador S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Residential Building Construction | Lessors of Real Estate | Marketing Research and Public Opinion Polling
Full name: Abl Pharma Ecuador S.A. Profile Updated: February 07, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Abl Pharma Ecuador S.A. is an enterprise located in Ecuador, with the main office in Quito. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on January 02, 2002. The total number of employees is currently 4 (2024). During that time, Abl Pharma Ecuador S.A.’s total assets decreased by 25.65%.

Headquarters
Paraiso Km. 6 1/12, Grunenthal Bldg.
Quito; Pichincha;

Contact Details: Purchase the Abl Pharma Ecuador S.A. report to view the information.

Website: http://www.ablpharma.com

Basic Information
Total Employees:
Purchase the Abl Pharma Ecuador S.A. report to view the information.
Registered Capital:
Purchase the Abl Pharma Ecuador S.A. report to view the information.
Financial Auditors:
Purchase the Abl Pharma Ecuador S.A. report to view the information.
Incorporation Date:
January 02, 2002
Key Executives
Purchase this report to view the information.
Administrative Manager
Purchase this report to view the information.
Administrative Manager
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Abl Pharma Ecuador S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Total Operating Revenue
359.24%
Operating Profit
531.86%
EBITDA
531.86%
Net Profit/Loss for the Period
711.36%
Total Assets
-25.65%
Total Equity
N/A
Return on Equity (ROE)
N/A
Debt / Equity
N/A
Quick Ratio
4.61%
Cash Ratio
4.61%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?